The 9.5 mm E-ring prevents posterior capsular opacification (PCO) in patients after cataract surgery.
An investigation published in the Archives of Ophthalmology shows that the 9.5 mm E-ring prevents posterior capsular opacification (PCO) in patients after cataract surgery.
Dr Tsutomu Hara et al., Hara Eye Hospital, Utsunomiya, Japan, studied 51 eyes that underwent cataract surgery and E-ring implantation. The patients were divided into three groups. Group 1 consisted of 14 patients who received an E-ring and IOL in one eye and just an IOL in the fellow eye. Group 2 included 37 eyes of 23 patients who received an E-ring and IOL in one or both eyes and 37 age-matched control eyes who received an IOL implant only. There was a follow-up period of 2 to 7 years and the PCO value was assessed using the Hayashi method.
The results found that, 2 years postoperatively, the PCO value in the central area of the eyes with an E-ring were considerably lower in group 1 than in the control eyes.
Patients who received an E-ring did not require additional postoperative Nd:YAG laser posterior capsulotomy compared with 23 of the 51 control eyes.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.